Gema Ruiz-Hurtado graduated in Biochemistry and Ph.D. degree in Pharmacology and Human Therapeutics. Her research activities have been focused on the study of new molecular targets involved in hypertension, cardiovascular and specially in cardiac damage as a consequence of renal disease. She has a strong experience in the analysis of Ca2+ handling at intracardiomyocyte level using confocal microscopy. She has authored more than 100 articles in international journals of first level, see: https://pubmed.ncbi.nlm.nih.gov/?term=ruiz-hurtado+g&sort=date https://www.researchgate.net/profile/Gema_Ruiz-Hurtado?ev=hdr_xprf&_sg=WzwM-zksxw4P6zRooGSI-HgIiDntxY9z27xmoID96VUFFfUo5f7vKUVDGAsf_qMC1fIHkfl7X7GtYEmCnBdjz0jj https://cardiorenallab.wixsite.com/ruizhurtado